FrancophonIA/ELRC3.0 huggingface dataset:
English: What measures are being taken to ensure the safe use of Omnitrope?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri anvendelse af Omnitrope?
English: For more information about treatment with Omnitrope, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Omnitrope, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: It is important for growth during childhood and adolescence, and it also affects how the body handles proteins, fat and carbohydrates.
Danish: Væksthormon er vigtigt for væksten hos børn og unge og har desuden betydning for stofskiftet af proteiner, fedtstoffer og kulhydrater.
English: • are short and were born small for their gestational age, and have not caught up by the age of
Danish: • børn, der har for lav kropshøjde, og som ved fødslen var for små i forhold til deres gestationsalder og ikke har indhentet dette inden 4-års alderen eller senere
English: The active substance in Omnitrope, somatropin, is identical to the human growth hormone, which it replaces.
Danish: Det aktive stof i Omnitrope, somatropin, er identisk med og erstatter det menneskelige væksthormon.
English: Omnitrope is also used as replacement therapy in adult patients with pronounced growth hormone deficiency.
Danish: Omnitrope anvendes desuden som erstatningsbehandling hos voksne patienter med udtalt væksthormonmangel.
English: Therefore, the Agency's view was that, as for Genotropin, the benefit outweighs the identified risk and it recommended that Omnitrope be given marketing authorisation.
Danish: Agenturet var derfor af den opfattelse, at fordelene opvejer de identificerede risici som for Genotropin, og anbefalede, at Omnitrope godkendes til anvendelse i EU.
English: The reference medicine for Omnitrope is Genotropin.
Danish: Referencelægemidlet for Omnitrope er Genotropin.
English: It is not intended to provide practical advice on how to use Omnitrope.
Danish: Det er ikke en praktisk vejledning i, hvordan Omnitrope bør anvendes.
English: What are the risks associated with Omnitrope?
Danish: Hvilke risici er der forbundet med Omnitrope?
English: Omnitrope is a medicine used to treat children who:
Danish: Omnitrope er et lægemiddel til behandling af:
English: The Omnitrope cartridges should only be used with the special Omnitrope injection device.
Danish: Omnitrope i cylinderampuller bør kun indgives ved hjælp af den særlige Omnitrope-indsprøjtningsanordning.
English: Howeve,r these antibodies do not have an effect on how well Omnitrope works.
Danish: Disse antistoffer har dog ingen betydning for, hvor godt Omnitrope virker.
English: • are short because they have long-term kidney disease or a genetic disorder called Turner syndrome;
Danish: • børn, der har for lav kropshøjde på grund af kronisk nyresygdom eller en genetisk defekt kaldet
English: For the full list of side effects of Omnitrope, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger ved Omnitrope fremgår af indlægssedlen.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Omnitrope have been included in the summary of product characteristics and the package leaflet.
Danish: Der er anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Omnitrope.
English: The medicine is available as a powder and solvent, which are made up into a solution for injection, or as a ready-to-use solution in a cartridge.
Danish: Omnitrope fås som et pulver med solvens, der blandes til en injektionsvæske (opløsning), eller som en færdigblandet opløsning i en cylinderampul.
English: For practical information about using Omnitrope, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Omnitrope, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: Growth hormone is released by the pituitary gland (a gland at the base of the brain).
Danish: Væksthormon udskilles af hypofysen (en kirtel, der ligger nederst i hjernen).
English: How is Omnitrope used?
Danish: Hvordan anvendes Omnitrope?
English: Omnitrope was studied to show that it is comparable to the reference medicine, Genotropin.
Danish: Undersøgelser har påvist, at Omnitrope er sammenligneligt med referencelægemidlet Genotropin.
English: What benefits of Omnitrope have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Omnitrope?
English: How does Omnitrope work?
Danish: Hvordan virker Omnitrope?
English: LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Danish: BILAG I FORTEGNELSE OVER LÆGEMIDLERNES NAVNE, LÆGEMIDDELFORM(ER), STYRKE(R), INDGIVELSESVEJ(E), ANSØGER(E), INDEHAVER(E) AF MARKEDSFØRINGSTILLADELSE(R) I MEDLEMSSTATERNE
English: Novartis Healthcare A/S Lyngbyvej 172
Danish: Danmark Novartis Healthcare A/S Lyngbyvej 172
English: 500mg/5ml Oral solution
Danish: 500 mg/5 ml Oral opløsning Oral anvendelse
English: Novartis Pharma GmbH Roonstrasse 25, 90429 Nuremberg
Danish: Bulgarien Novartis Pharma GmbH Roonstrasse 25, 90429
English: Belgium N.V. Novartis Pharma S.A. Medialaan 40,
Danish: Novartis Pharma S.A. Medialaan 40, B-1800 Vilvoorde Belgium
English: Trinklösung
Danish: Den
English: SANDIMMUN NEORAL, solutie orala, 100 mg/ml
Danish: SANDIMMUN NEORAL,emulsie orală, 100 mg/ml
English: Sandimmun Neoral 100 mg mīkstās kapsulas
Danish: Sandimmun Neoral 100 mg minkštos kapsulės
English: Sandimmun Neoral 100 mg capsule
Danish: Sandimmun Neoral 100 mg capsules
English: Sandimmun Neoral 25 mg mīkstās kapsulas
Danish: Sandimmun Neoral 25 mg minkštos kapsulės
English: Sandimmun Neoral 50 mg mīkstās kapsulas
Danish: Sandimmun Neoral 50 mg minkštos kapsulės
English: Sandimmun Neoral 25 mg capsule
Danish: Sandimmun Neoral 25 mg capsules
English: Sandimmun Neoral 50 mg capsule
Danish: Sandimmun Neoral 50 mg capsules
English: Sandimmun Neoral 100 mg/ml belsőleges oldat
Danish: 100 mg/ml belsőleges oldat
English: Sandimmun - Neoral 100 mg Kapseln
Danish: Sandimmun Neoral 100 mg kapsler
English: Sandimmun - Neoral 25 mg Kapseln
Danish: Sandimmun Neoral 25 mg kapsler
English: Sandimmun - Neoral 50 mg Kapseln
Danish: Sandimmun Neoral 50 mg kapsler
English: Sandimmun - Neoral 10 mg Kapseln
Danish: Sandimmun Neoral 10 mg capsule molli
English: The United Kingdom is the reference Member State and Germany and the Netherlands are concerned Member States.
Danish: Det Forenede Kongerige er referencemedlemsstat, og Tyskland og Nederlandene er berørte medlemsstater.
English: International non-proprietary name (INN): eprinomectin
Danish: Internationalt fællesnavn (INN): eprinomectin
English: The opinion was converted into a Decision by the European Commission on 21 March 2014.
Danish: Udtalelsen blev den 21. marts 2014 omarbejdet til en beslutning af Europa-Kommissionen.
English: The decentralised procedure started on 21 February 2012.
Danish: Den decentrale procedure blev indledt den 21. februar 2012.
English: The Committee appointed C. Ibrahim as rapporteur and H. Jukes as co-rapporteur.
Danish: Som rapportør og medrapportør udpegede udvalget henholdsvis C. Ibrahim og H. Jukes.
English: Written explanations were provided by the applicant on 19 November
Danish: Ansøgeren indsendte skriftlige redegørelser den 19. november 2013.
English: The referral procedure started on 15 May 2013.
Danish: Henvisningsproceduren blev indledt den 15. maj 2013.
English: Day 60 of the CMD(v) procedure was on 18 April 2013, and since the Member States concerned failed to reach an agreement regarding the product the procedure was referred to the CVMP.
Danish: Dag 60 af proceduren i CMD(v) var den 18. april 2013, og da de berørte medlemsstater ikke var i stand til at nå til enighed vedrørende produktet, blev proceduren indbragt for CVMP.
English: The list of product names concerned is given in Annex I. The scientific conclusions are provided in Annex II, together with the summary of product characteristics and package leaflet in Annex III.
Danish: Listen over de berørte produktnavne fremgår af bilag I. De videnskabelige konklusioner fremgår af bilag II.
English: On 26 April 2013, the reference Member State, the United Kingdom, notified the Agency that the CMD(v) had failed to reach an agreement regarding the product and referred the matter to the CVMP pursuant to Article 33(4) of Directive 2001/82/EC.
Danish: Den 26. april 2013 underrettede referencemedlemsstaten, Det Forenede Kongerige, agenturet om, at CMD(v) ikke havde været i stand til at nå til enighed vedrørende produktet, og indbragte sagen for CVMP i medfør af artikel 33, stk. 4, i direktiv 2001/82/EF.
English: Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle contains eprinomectin as an active substance and is intended for use in cattle as a topical application for the treatment and control of infections from gastrointestinal roundworms (adults and fourth stage larvae), lungworms (adults and fourth stage larvae), warbles (parasitic stages), mange mites, lice and horn flies.
Danish: Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg indeholder eprinomectin som aktivt stof og er bestemt til topikal anvendelse hos kvæg til behandling og kontrol af angreb af gastrointestinale rundorm (voksne og larver i fjerde stadium), lungeorm (voksne og larver i fjerde stadium), bremselarver (parasitære stadier), skabmider, lus og stikfluer.
English: This is a ‘hybrid' application according to Article 13(3) of Directive 2001/82/EC, as amended, referring to the reference product Eprinex PourOn Solution for Beef and Dairy Cattle.
Danish: Ansøgningen er en “hybrid ansøgning” i henhold til artikel 13, stk. 3, i direktiv 2001/82/EF, som ændret, idet ansøgningen henviser til et referenceprodukt, Eprinex, pour-on, opløsning, til kødkvæg og malkekvæg.
English: Therefore, the Committee adopted by consensus a positive opinion on 15 January 2014 recommending the granting of the marketing authorisations for Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle with amendment to the summary of product characteristics and package leaflet of the reference Member State.
Danish: Udvalget vedtog derfor den 15. januar 2014 enstemmigt en positiv udtalelse, der anbefalede udstedelse af markedsføringstilladelser for Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg, med ændring af produktresuméet og indlægssedlerne i referencemedlemsstaten.
English: On day 210, these issues remained unsolved and therefore a referral under Article 33(1) of Directive 2001/82/EC to the Coordination group for Mutual recognition and Decentralised procedures (veterinary) (CMD(v)) was started on 18 February 2013.
Danish: Den 18. februar 2013 blev sagen derfor i medfør af artikel 33, stk. 1, i direktiv 2001/82/EF indbragt for koordinationsgruppen vedrørende gensidig anerkendelse og decentrale procedurer - veterinær (CMD(v)).
English: The applicant, Norbrook Laboratories Ltd, submitted an application for a decentralised procedure for Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle.
Danish: Ansøgeren, Norbrook Laboratories Ltd, har indgivet en ansøgning via den decentrale procedure for Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg.
English: Based on the evaluation of the currently available data, the CVMP considered that the benefit-risk profile of Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle is positive.
Danish: Efter vurdering af de foreliggende data fandt CVMP, at benefit/risk-forholdet for Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg er positivt.
English: Opinion following an Article 33(4)1 referral for Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle
Danish: Udtalelse efter en artikel 33, stk. 4-indbringelse1 for Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg
English: Opinion following an Article 33(4)0F referral for Norbonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle
Danish: Udtalelse efter en artikel 33, stk. 4-indbringelse0F for Norbonex, pour-on, opløsning, 5 mg/ml, til kødkvæg og malkekvæg
English: It can cause:
Danish: Det kan forårsage:
English: Your veterinarian can best describe these for you.
Danish: Din dyrlæge kan bedst beskrive disse for dig.
English: • Your dog to feel cold when touched (for example the ears).
Danish: • Din hund føles kold, når du mærker efter (for eksempel ørerne).
English: 1.3 - Not Reached
Danish: 1,3 - Ikke nået
English: • Loss of appetite or drinking less water.
Danish: • Manglende appetit eller drikker mindre mængder vand.
English: This dog was treated on: Date
Danish: Denne hund blev behandlet: Dato
English: Reversal should occur rapidly within 1-2 minutes.
Danish: Ophævelsen skal finde sted hurtigt inden for 1-2 minutter.
English: Repeat until the entire calculated volume has been applied to the dog.
Danish: Gentag indtil hele den beregnede mængde er blevet anvendt på hunden.
English: Such data should be submitted to the Agency together with the periodic safety update reports.
Danish: Sådanne data skal indsendes til EMA sammen med de periodiske sikkerhedsopdateringsrapporter.
English: 6.2 Incompatibilities None known.
Danish: 6.2 Væsentlige uforligeligheder Ingen kendte.
English: Therefore, special precautions should be taken by people whose dogs have been treated with Recuvyra.
Danish: Der skal derfor træffes særlige forholdsregler af mennesker, hvis hunde er blevet behandlet med Recuvyra.
English: Within 5 minutes, the product dries on the skin.
Danish: Inden for 5 minutter tørrer produktet på huden.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/11/127/001
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/11/127/001
English: • To your dog if it has already had a dose of Recuvyra within the last 7 days.
Danish: • til din hund, hvis den allerede har fået en dosis Recuvyra inden for de sidste 7 dage.
English: 3.0 to 4.2 4.3 to 6.1 6.2 to 8.0 8.1 to 9.9 10.0 to 11.7 11.8 to 13.6 13.7 to 15.5 15.6 to 17.4 17.5 to 19.3 19.4 to 21.2 21.3 to 23.1 23.2 to 25.0 25.1 to 26.9 27.0 to 28.8 28.9 to 30.6 30.7 to 32.5 32.6 to 34.4 34.5 to 36.3 36.4 to 38.2 38.3 to 40.1 40.2 to 42.0 42.1 to 43.9 44.0 to 45.8 45.9 to 47.7 47.8 to 49.6 49.7 to 51.4 51.5 to 53.3 53.4 to 55.2 55.3 to 57.0
Danish: 3,0 til 4,2 4,3 til 6,1 6,2 til 8,0 8,1 til 9,9 10,0 til 11,7 11,8 til 13,6 13,7 til 15,5 15,6 til 17,4 17,5 til 19,3 19,4 til 21,2 21,3 til 23,1 23,2 til 25,0 25,1 til 26,9 27,0 til 28,8 28,9 til 30,6 30,7 til 32,5 32,6 til 34,4 34,5 til 36,3 36,4 til 38,2 38,3 til 40,1 40,2 til 42,0 42,1 til 43,9 44,0 til 45,8 45,9 til 47,7 47,8 til 49,6 49,7 til 51,4 51,5 til 53,3 53,4 til 55,2 55,3 til 57,0
English: It is important that both tips make direct contact with the skin.
Danish: Det er vigtigt, at begge spidser har direkte kontakt med huden.
English: Recuvyra should only be used for dogs.
Danish: Recuvyra bør kun anvendes til hunde.
English: As a precaution, RECUVYRA should not be administered by pregnant women.
Danish: Som en sikkerhedsforanstaltning bør RECUVYRA ikke indgives af gravide kvinder.
English: If needed, re-administer naloxone.
Danish: Om nødvendigt indgives naloxon igen.
English: The systemic bioavailability of the veterinary medicinal product is approximately 40%.
Danish: Veterinærlægemidlets systemiske biotilgængelighed er ca. 40 %.
English: Mild reductions in body temperature and heart and respiratory rates for up to 3 days following use are common.
Danish: Milde reduktioner i kropstemperatur og hjerte- og respiratorisk hastighed i op til 3 dage efter anvendelse er almindelige.
English: The duration of action of naloxone ranges between 45 minutes and 3 hours in the dog.
Danish: Naloxonvirkningens varighed ligger mellem 45 minutter og 3 timer hos hunden.
English: Rarely (i.e. in 0,01 to 0,1% of treated dogs) • Dysphoria and urinary retention.
Danish: Sjældent (dvs. hos 0,01 til 0,1 % af behandlede hunde) • Dysfori og urinretention.
English: Your dog should not be given Recuvyra if it:
Danish: Din hund skal ikke have Recuvyra, hvis den:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
Danish: KVALITATIV OG KVANTATIV SAMMENSÆTNING Aktivt stof:
English: Your veterinarian will ensure the product is stored correctly and safely for up to 3 years, but the contents of a bottle should be used within 30 days of the first dose being withdrawn.
Danish: Din dyrlæge vil sikre, at produktet opbevares korrekt og sikkert i op til 3 år, men indholdet af flasken skal anvendes inden for 30 dage efter, at den første dosis er blevet tappet.
English: Site preparation: It is not necessary to clip the hair over the application site.
Danish: Forberedelse af stedet: Det er ikke nødvendigt at fjerne håret over applikationsstedet.
English: • Except as a single dose at the recommended dose rate.
Danish: • medmindre det er som en enkelt dosis ved den anbefalede dosishastighed.
English: ATCvet code: QN02AB03
Danish: ATCvet-kode: QN02AB03
English: • Mild sedation (sleepiness) for up to 24 hours after Recuvyra has been applied by your veterinarian.
Danish: • Mild sedation (søvnighed) i op til 24 timer efter Recuvyra er blevet påført af din dyrlæge.
English: The veterinary medicinal product has a narrow margin of safety and it is important to measure the dose accurately to avoid over-dosing.
Danish: Veterinærlægemidlet har en smal sikkerhedsmargin og det er vigtigt at måle dosen nøjagtigt for at undgå overdosering.
English: After the application site is dry, direct contact to the application site should not pose a risk to adults.
Danish: Når applikationsstedet er tørt, bør direkte kontakt med applikationsstedet ikke udgøre en risiko for voksne.
English: Your dog will only be allowed to go home once it has recovered from its surgery, and is drinking and eating normally.
Danish: Din hund vil kun få lov til at komme hjem, når den er kommet sig efter dens operation og drikker og spiser normalt.
English: Dispose of waste material in accordance with local requirements
Danish: Bortskaf affald i overensstemmelse med de lokale krav.
English: For transdermal use.
Danish: Til transdermal anvendelse.
English: Sedation may persist beyond 24 hours after application.
Danish: Sedation kan vare mere end 24 timer efter applikation.
English: If necessary, your veterinarian may administer treatment to your dog (for example a reversal agent called naloxone which has a very rapid effect within 1 - 2 minutes).
Danish: Om nødvendigt kan din dyrlæge give din hund en behandling (for eksempel en antidot ved navn naloxon, som har en meget hurtig virkning inden for 1-2 minutter).
English: Avoid contact with skin, as Recuvyra can be absorbed by human skin.
Danish: Undgå kontakt med huden, da Recuvyra kan absorberes af menneskers hud.
English: If there is a risk of contact with the application site, suitable protective gloves must be worn.
Danish: Hvis der er risiko for kontakt med applikationsstedet, skal der bæres egnede beskyttelseshandsker.
English: Your veterinarian received a separate information sheet (summary of product characteristics) with more details on the correct and safe administration of Recuvyra.
Danish: Din dyrlæge modtog et separat informationsblad (produktresume) med yderligere detaljer om korrekt og sikker indgivelse af Recuvyra.
English: Time to 1.0 ng/ml (hrs)
Danish: Tid til 1,0 ng/ml (timer)
English: Fentanyl plasma protein binding is estimated at approximately 60% in dogs.
Danish: Fentanyls plasmaproteinbinding skønnes at være ca. 60 % hos hunde.
English: • To anywhere except between your dogs shoulder blades.
Danish: • nogetsteds, medmindre det er mellem din hunds skulderblade.
English: As Recuvyra contains fentanyl (the active substance), it will only ever be kept in a veterinarian's surgery under secure conditions.
Danish: Da Recuvyra indeholder fentanyl (det aktive stof), vil det kun blive opbevares på en dyrlæges operationsstue under sikre forhold.
English: The ranges (90% interval) of pharmacokinetic parameters in dogs are given below:
Danish: De farmakokinetiske parametres områder (90 % interval) hos hunde er opgivet nedenfor:
English: Tell your veterinarian if your dog is sick or was recently ill, if it has ever had breathing, heart or blood pressure problems or epilepsy, if it has ever had bowel or kidney problems or problems with its eyes, and what medicines your dog has taken, especially within the last month.
Danish: Fortæl din dyrlæge, hvis din hund er syg eller var syg for nyligt, hvis den nogensinde har haft vejrtræknings-, hjerte- eller blodtryksproblemer eller epilepsi, hvis den nogensinde har haft tarm- eller nyreproblemer eller problemer med dens øjne og hvilke veterinærlægemidler din hund har taget, særligt inden for den sidste måned.
English: Pharmacotherapeutic group: Analgesic, opioid, phenylpiperidene derivative.
Danish: Farmakoterapeutisk kategori: Analgetika, opioid, phenylpiperidenderivat.
English: Laboratory studies conducted in rats have not shown any evidence of teratogenic effect, or any adverse effect on fertility or embryo-foetal development.
Danish: Laboratorieundersøgelser, der blev foretaget på rotter, har ikke påvist beviser på teratogen virkning eller bivirkninger på fertilitet eller fosterudviklingen.
English: Each pack is supplied with one vial adaptor, 15 syringes and 15 applicator tips, as well as 15 package leaflets for animal owners, and 1 SPC (for the veterinarian).
Danish: Hver pakke leveres med en hætteglasadapter, 15 sprøjter og 15 applikatorspidser samt 15 indlægssedler til dyreejere og 1produktresume (til dyrlægen).
English: Keep this package leaflet in a safe place.
Danish: Opbevar denne indlægsseddel på et sikkert sted.
English: The veterinary medicinal product is strictly limited for use in dogs.
Danish: Veterinærlægemidlets anvendelse er strengt begrænset til hunde.
English: Recuvyra is supplied to your veterinarian in an amber glass bottle containing 10 ml of product.
Danish: Recuvyra leveres til din dyrlæge i en ravgul glasflaske med 10 ml produkt.
English: If needed, your veterinarian might administer more than one dose of naloxone to your dog.
Danish: Om nødvendigt kan din dyrlæge indgive mere end en dosis af naloxon til din hund.
English: Recuvyra like any other medicine may cause adverse reactions.
Danish: Recuvyra kan som ethvert andet lægemiddel forårsage bivirkninger.
English: Additional class effects that may be observed following administration of fentanyl include dysphoria and urinary retention, therefore appropriate precautionary measures should be in place.
Danish: Yderligere klasseeffekter, som kan observeres efter administration af Fentanyl, omfatter dysfori og urinretention og passende sikkerhedsforanstaltninger bør derfor være på plads.
English: • Has broken, damaged or diseased skin at the treatment site.
Danish: • Har sår, beskadiget eller syg hud på behandlingsstedet.
English: Unless your dog has thick hair it will not usually be necessary to clip/ shave your dog's hair between the shoulder blades for correct application.
Danish: Medmindre din hund har en tyk pels, vil det ikke normalt være nødvendigt at fjerne hundens hår mellem skulderbladene for korrekt anvendelse.
English: The pharmacokinetic profile of the veterinary medicinal product is primarily characterised by the long period of systemic absorption.
Danish: Veterinærlægemidlets farmakokinetiske profil karakteriseres primært af den lange systemiske absorptionsperiode.
English: Recuvyra also contains octyl salicylate and isopropyl alcohol.
Danish: Recuvyra indeholder også octylsalicylat og isopropylalcohol.